Israel -
Hebräisch -
Ministry of Health
טקפידרה 120 מג
medison pharma ltd - dimethyl fumarate - dimethyl fumarate 120 mg - dimetyl fumarate
Israel -
Hebräisch -
Ministry of Health
טקפידרה 240 מג
medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate
Israel -
Hebräisch -
Ministry of Health
טקפידרה 240 מג
medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate
Israel -
Hebräisch -
Ministry of Health
טקפידרה 240 מג
medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate
Israel -
Hebräisch -
Ministry of Health
טקפידרה 240 מג
medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate
Israel -
Hebräisch -
Ministry of Health
טקפידרה 240 מג
medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate
Israel -
Hebräisch -
Ministry of Health
טקפידרה 240 מג
medison pharma ltd - dimethyl fumarate - dimethyl fumarate 240 mg - dimetyl fumarate
Israel -
Hebräisch -
Ministry of Health
קו-דיובאן 8012.5 מג טבליות מצופות
novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.
Israel -
Hebräisch -
Ministry of Health
קו-דיובאן 16012.5 מג טבליות מצופות
novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.
Israel -
Hebräisch -
Ministry of Health
קו-דיובאן 16025 מג טבליות מצופות
novartis israel ltd - hydrochlorothiazide; valsartan - טבליות מצופות פילם - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.